Swiss Biotech Day 2026: Valais plays a leading role on the international life sciences stage
The Valais region was represented at Swiss Biotech Day.
The Swiss Biotech Report 2026 places Valais in a strong position
Switzerland has confirmed its status as a global biotech power. But beyond the impressive national figures, the regional ecosystem in Valais is also thriving, following the example of its two emblematic locations in Viège and Monthey. Our region is asserting its position as an indispensable ecosystem in the Swiss life sciences value chain. The Swiss […]
Bioscibex reaches semi-finals of one of Switzerland’s leading startup competitions
The start-up Bioscibex has been selected as one of the 60 semi-finalists in the “Venture 2026” competition.
BioArk and New Mexico Venture Studios partner to accelerate transatlantic life sciences collaboration
BioArk and New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep tech.
Bioscibex secures CHF 100,000 Venture Kick phase III award
Bioscibex has won the final stage of the Venture Kick program, receiving CHF 100,000 to accelerate the development of its next-generation single-use bioreactors.
Valais-based SME Lugaia celebrates 10 years of success in Germany
Valais-based SME Lugaia, which specializes in sterile packaging solutions for the pharmaceutical and life sciences industries, is celebrating the tenth anniversary of its German subsidiary this year.
Start-up Bioscibex has set up at BioArk in Monthey
Start-up Bioscibex, which grew out of an EPFL research laboratory, is on a mission to transform the manufacture of biological medicines.
AlphaOnco: from research to business start-up
A new method to cure prostate cancer: AlphaOnco Swiss is banking on an innovative, user-friendly and affordable treatment.
A rapid diagnostic test against antimicrobial-resistant bacteria, developed by the Valais-based start-up GaDia
The Valais-based start-up GaDia launches an innovative test to detect, in only 15 minutes, carbapenem-resistant bacteria.
The Upper Valais SME Adryan ensures the accreditation of pharmaceutical installations
Adryan supports its customers throughout the life cycle of pharmaceutical installations.
